Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Oncopeptides AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 32,639 More Arrow 36,772 Less Arrow 7,903
Financial expenses 17,135 Less Arrow 5,860 Less Arrow 835
Earnings before taxes -293,104 More Arrow -251,685 Less Arrow -319,416
EBITDA -289,822 More Arrow -245,566 Less Arrow -314,202
Total assets 251,835 Less Arrow 241,484 More Arrow 364,482
Current assets 223,875 Less Arrow 205,544 More Arrow 344,344
Current liabilities 52,962 Less Arrow 45,519 More Arrow 78,679
Equity capital 55,984 More Arrow 57,520 More Arrow 278,375
- share capital 24,658 Less Arrow 10,648 Less Arrow 9,912
Employees (average) 66 Less Arrow 52 More Arrow 57

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 22.2% More Arrow 23.8% More Arrow 76.4%
Turnover per employee 495 More Arrow 707 Less Arrow 139
Profit as a percentage of turnover -898.0% More Arrow -684.4% Less Arrow -4041.7%
Return on assets (ROA) -109.6% More Arrow -101.8% More Arrow -87.4%
Current ratio 422.7% More Arrow 451.6% Less Arrow 437.7%
Return on equity (ROE) -523.5% More Arrow -437.6% More Arrow -114.7%
Change turnover -4,797 More Arrow 28,308 Less Arrow -103,994
Change turnover % -13% More Arrow 334% Less Arrow -93%
Chg. No. of employees 14 Less Arrow -5 Less Arrow -172
Chg. No. of employees % 27% Less Arrow -9% Less Arrow -75%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.